MacroGenics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ANTX
AN2 Therapeutics, Inc. |
$1.38 | $60.55 M | -0.81 | 41 | $0 |
CCCC
C4 Therapeutics, Inc. |
$4.09 | $320.64 M | -1.97 | 110 | $20.76 M |
CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
INZY
Inozyme Pharma, Inc. |
$2.89 | $286.39 M | -3.43 | 67 | $0 |
IPSC
Century Therapeutics, Inc. |
$1.05 | $244.54 M | -1.32 | 152 | $2.24 M |
KZR
Kezar Life Sciences, Inc. |
$6.65 | $49.85 M | -0.49 | 58 | $7.00 M |
MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
MOLN
Molecular Partners AG |
$5.06 | $135.05 M | -2.03 | 158 | $4.97 M |
NGM
NGM Biopharmaceuticals, Inc. |
$1.54 | $128.53 M | -0.89 | 138 | $4.42 M |
NKTX
Nkarta, Inc. |
$2.46 | $465.09 M | -2.81 | 159 | $0 |
PEPG
PepGen Inc. |
$3.68 | $537.15 M | -5.11 | 81 | $0 |
PHVS
Pharvaris N.V. |
$18.06 | $843.31 M | -5.8 | 92 | $0 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.57 | $85.40 M | -1.26 | 47 | $0 |
PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
SNDX
Syndax Pharmaceuticals, Inc. |
$13.69 | $1.66 B | -6.02 | 270 | $23.68 M |
TYRA
Tyra Biosciences, Inc. |
$16.06 | $1.04 B | -11.7 | 49 | $0 |
ZNTL
Zentalis Pharmaceuticals, Inc. |
$3.13 | $754.16 M | -3.26 | 124 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
